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of improving reﬁll rates. This leads to improved medica-
tion compliance and improved clinical outcomes. Because
selected medications were also formulary-preferred
agents, formulary compliance and volume within several
key therapeutic categories was enhanced.
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OBJECTIVES: To compare survival in sedated ICU
patients by hospital type and to investigate various factors
associated with patient survival.
METHODS: Data from 622 patients admitted to the
ICU, intubated more than 24 hours, and receiving seda-
tives/analgesics during intubation were collected from 
42 hospitals from November 22, 1999 to March 4, 2000.
Patient demographic, sedative and analgesic selection,
and outcome data were recorded on standard data forms.
The Kaplan-Meier (KM) survival curves and the Cox pro-
portional hazard model were used to examine the effect
of hospital type and other factors on patient survival.
RESULTS: Patients in teaching hospitals had a signiﬁ-
cantly higher survival rate compared to community hos-
pitals (p < 0.02). The Cox regression analyses showed
that patient mortality was signiﬁcantly associated with
older age (hazard ratio; HR = 1.03), higher severity of
illness (HR = 1.04), having certain comorbid conditions
[lymphoma (HR = 2.87) and chronic hypoxia (HR =
2.57)], receiving analgesic agents (e.g., morphine, hydro-
morphone, and fentanyl) (HR = 2.76) and receiving care
in a community hospital (HR = 0.62). However, whether
the patient received treatment consistent with practice
guidelines for ICU sedation and was treated in a hospital
with a care plan for ICU sedation had no signiﬁcant
impact on patient survival in this analysis.
CONCLUSIONS: The results suggest that patients 
admitted to teaching hospitals seem to have better sur-
vival compared to community hospitals controlling for
other factors that impact patient outcomes. However,
whether this is due to hospital type, some other patient
care practice or patient factors needs to be determined.
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OBJECTIVE: This evidence-based review evaluates the
therapeutic interchangeability of levothyroxine between
the original product Synthroid, and the two major 
generic brands Levoxyl and Levothroid, for use in
hypothyroidism.
METHODS: A literature search identiﬁed 8 bioequiva-
lence trials comparing different formulations of levothy-
roxine tablets. Meta-analyses were conducted to compare
average bioavailability using three pharmacokinetic mea-
sures (Total T4, Thyrotropin-stimulating Hormon [TSH],
and Free Thyroxine Index [FTI]). These measures were
also evaluated for differences in variability between treat-
ment groups.
RESULTS: The three formulations of Synthroid, Levoxyl,
and Levothroid can be expected to produce similar
average levels of circulating total T4 and TSH at steady
state. Due to limited data, this statement does not extend
to levels of free T4 nor free T3. Meta-analyses suggest
that differences may exist in the variability of effect 
of levothyroxine products. Speciﬁcally, individual TSH
levels in treated hypothyroid patients may span a wider
range with some products than with others. This vari-
ability may be due to true individual differences in the
variability of absorption of these products or to the use
of outdated assay techniques (ﬁrst generation radio-
immunoassay) and short study durations that do not
allow enough time for the patient to reach steady-state.
CONCLUSION: Studies generally suggest that Synthroid,
Levoxyl, and Levothroid are bioequivalent on average.
However, population (between subject) variability may 
be different across products. Establishment of individual
bioequivalence will require new, prospective studies of
adequate treatment duration that use the most sensitive
assay methodologies. Until such studies are undertaken,
current treatment guidelines that recommend hypo-
thyroid patients be reassessed 6 weeks after a change 
in brand or dose should remain in effect.
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OBJECTIVES: The American Productivity Audit (APA),
an on-going week-to-week telephone survey, provides
valid and reliable estimates of health-related work loss.
The APA is currently being used to generate tailored
reports for employers to inform them of the lost produc-
tive work time associated with speciﬁc health conditions.
The paper illustrates the process.
METHODS: We developed and validated the Work and
Health Interview (WHI) for APA administration. The
WHI quantiﬁes missed work hours and lost productive
time while at work for speciﬁc health conditions using
